BlossomHill Therapeutics adopts amended, restated bylaws ahead of IPO close
BLSM•Amended bylaws and certificate take effect around IPO close
- BlossomHill Therapeutics adopted amended and restated bylaws effective Aug. 10, 2026, tied to the closing of its IPO.
- The company also filed an amended and restated certificate of incorporation in Delaware, effective immediately before the IPO close.
- The IPO closed Aug. 10 with 9,375,000 common shares sold at $16 per share, generating about $150 million in gross proceeds.
